These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15995351)
1. P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin. Gao Y; Li N; Fei R; Chen Z; Zheng S; Zeng X Mol Cells; 2005 Jun; 19(3):350-5. PubMed ID: 15995351 [TBL] [Abstract][Full Text] [Related]
2. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo. Wan JG; Mu JS; Zhu HS; Geng JG Inflamm Res; 2002 Sep; 51(9):435-43. PubMed ID: 12365716 [TBL] [Abstract][Full Text] [Related]
3. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. Wang L; Brown JR; Varki A; Esko JD J Clin Invest; 2002 Jul; 110(1):127-36. PubMed ID: 12093896 [TBL] [Abstract][Full Text] [Related]
4. Chemically modified heparin inhibits in vitro L-selectin-mediated human ovarian carcinoma cell adhesion. Chen Z; Jing Y; Song B; Han Y; Chu Y Int J Gynecol Cancer; 2009 May; 19(4):540-6. PubMed ID: 19509548 [TBL] [Abstract][Full Text] [Related]
5. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Nelson RM; Cecconi O; Roberts WG; Aruffo A; Linhardt RJ; Bevilacqua MP Blood; 1993 Dec; 82(11):3253-8. PubMed ID: 7694675 [TBL] [Abstract][Full Text] [Related]
6. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment. Borsig L; Wang L; Cavalcante MC; Cardilo-Reis L; Ferreira PL; Mourão PA; Esko JD; Pavão MS J Biol Chem; 2007 May; 282(20):14984-91. PubMed ID: 17371880 [TBL] [Abstract][Full Text] [Related]
7. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate. Xie X; Rivier AS; Zakrzewicz A; Bernimoulin M; Zeng XL; Wessel HP; Schapira M; Spertini O J Biol Chem; 2000 Nov; 275(44):34818-25. PubMed ID: 10944519 [TBL] [Abstract][Full Text] [Related]
9. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030 [TBL] [Abstract][Full Text] [Related]
10. Peptides inhibit selectin-mediated cell adhesion in vitro, and neutrophil influx into inflammatory sites in vivo. Briggs JB; Oda Y; Gilbert JH; Schaefer ME; Macher BA Glycobiology; 1995 Sep; 5(6):583-8. PubMed ID: 8563145 [TBL] [Abstract][Full Text] [Related]
11. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity. Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802 [TBL] [Abstract][Full Text] [Related]
12. Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells. Wei M; Gao Y; Tian M; Li N; Hao S; Zeng X Cancer Lett; 2005 Nov; 229(1):123-6. PubMed ID: 16157224 [TBL] [Abstract][Full Text] [Related]
13. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. Koenig A; Norgard-Sumnicht K; Linhardt R; Varki A J Clin Invest; 1998 Feb; 101(4):877-89. PubMed ID: 9466983 [TBL] [Abstract][Full Text] [Related]
14. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Stevenson JL; Varki A; Borsig L Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703 [TBL] [Abstract][Full Text] [Related]
15. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin. Li Y; Luo JY; Cui HF; Zheng L; Du SS Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300 [TBL] [Abstract][Full Text] [Related]
16. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. Gao Y; Wei M; Zheng S; Ba X; Hao S; Zeng X J Cancer Res Clin Oncol; 2006 Apr; 132(4):257-64. PubMed ID: 16331491 [TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells. Luo J; Kato M; Wang H; Bernfield M; Bischoff J J Cell Biochem; 2001; 80(4):522-31. PubMed ID: 11169736 [TBL] [Abstract][Full Text] [Related]
18. Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity. Stevenson JL; Choi SH; Varki A Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7003-11. PubMed ID: 16203794 [TBL] [Abstract][Full Text] [Related]
19. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives. Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706 [TBL] [Abstract][Full Text] [Related]
20. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]